全文获取类型
收费全文 | 1239篇 |
免费 | 185篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 54篇 |
妇产科学 | 20篇 |
基础医学 | 81篇 |
口腔科学 | 38篇 |
临床医学 | 206篇 |
内科学 | 269篇 |
皮肤病学 | 104篇 |
神经病学 | 39篇 |
特种医学 | 132篇 |
外科学 | 185篇 |
综合类 | 94篇 |
现状与发展 | 30篇 |
预防医学 | 51篇 |
眼科学 | 15篇 |
药学 | 31篇 |
中国医学 | 3篇 |
肿瘤学 | 70篇 |
出版年
2024年 | 18篇 |
2023年 | 179篇 |
2022年 | 12篇 |
2021年 | 16篇 |
2020年 | 55篇 |
2019年 | 21篇 |
2018年 | 51篇 |
2017年 | 45篇 |
2016年 | 39篇 |
2015年 | 55篇 |
2014年 | 82篇 |
2013年 | 60篇 |
2012年 | 25篇 |
2011年 | 29篇 |
2010年 | 73篇 |
2009年 | 87篇 |
2008年 | 28篇 |
2007年 | 50篇 |
2006年 | 18篇 |
2005年 | 17篇 |
2004年 | 10篇 |
2003年 | 14篇 |
2002年 | 15篇 |
2001年 | 10篇 |
2000年 | 14篇 |
1999年 | 27篇 |
1998年 | 35篇 |
1997年 | 49篇 |
1996年 | 40篇 |
1995年 | 35篇 |
1994年 | 29篇 |
1993年 | 34篇 |
1992年 | 7篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 22篇 |
1988年 | 20篇 |
1987年 | 14篇 |
1986年 | 4篇 |
1985年 | 11篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 12篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 13篇 |
1975年 | 10篇 |
1974年 | 3篇 |
排序方式: 共有1442条查询结果,搜索用时 15 毫秒
991.
992.
Ying Wang MM Lixin Chen MM Ji Wang MM Yawei Bian MM Qinfeng Li MM 《The Australasian journal of dermatology》2023,64(2):e160-e161
A boy with a 2-year history of asymptomatic, linear pigmented macules involving the right side of the trunk and right upper limb. RCM revealed the dermal papillary rings were destroyed, and numerous irregular particulate structures with high refractive values were distributed in the superficial dermis. The RCM features implied the possibility of interface dermatitis. RCM was a complementary diagnostic tool for linear pigmented macules. 相似文献
993.
Fengli Jiang MMD Xueshang Su MM Yuduo Dai MD Hang Shen MM Jintian Hu MD Lingsong Wu MBBS Yuanyuan Wu MM Sien Zhan MD 《Journal of Cosmetic Dermatology》2023,22(5):1575-1584
Objective
By analyzing the distribution and drug resistance of common pathogen in different sites in plastic surgery to provide reference for clinicians to choose the best antibacterial treatment plan.Methods
Pathogens of postoperative infection in plastic surgery from January 2011 to December 2021 were retrospectively analyzed to determine the species and quantity, and to access the trend of each pathogen's detection rate. The antibiotic sensitivity and distribution characteristics of common pathogens were studied in conjunction with the site of infection.Results
A total of 1709 bacterial strains were detected, including 1244 gram-positive bacterial strains and 465 gram-negative bacterial strains. The main pathogen of perineum was Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa), while Staphylococcus aureus (S. aureus) was the most common pathogen in the other infected sites. The detection rate of methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococcus (MRCNS) was on the rise from 2011 to 2021. No S. aureus and coagulase-negative staphylococcus (CoNS) strains were resistant to vancomycin. The sensitive rate of S. aureus from all parts and CoNS from all sites except lower limbs and mandible was higher than 80% to linezolid. The resistance rate of S. aureus and CoNS in all parts to penicillin, clindamycin, and erythromycin was high. The susceptibility rate of CoNS in lower mandible was high to gentamicin.Conclusions
Staphylococcus aureus was the primary pathogen of gram-positive bacteria in all site of plastic surgery except perineum, followed by CoNS. The distribution and drug resistance of pathogen in different infection sites were different. We should formulate more accurate and reasonable antibacterial programs according to drug resistance results of various parts to reduce the emergence of resistant strains and effectively prevent and control infection. 相似文献994.
Background
Various biologic agents targeting specific molecules present new treatment options for various tumors. Acneiform eruption is a very common skin reaction to these agents. Although not life-threatening, acneiform eruption can affect patients' emotional and social lives. In very exceptional cases, it can lead to cancer therapy interruption.Aims
The aim of this study was to review the incidence rate, clinical characteristics, pathogenesis, and current management of acneiform eruption induced by molecularly targeted agents.Methods
This review was carried out through PubMed, Embase, and Cochrane searching terms ‘acneiform eruption’, ‘papulopustular eruption’ or ‘acne-like rash’ and ‘skin toxicity’, ‘cutaneous toxicity’, ‘skin reactions’, ‘dermatological toxicities’, ‘target therapy,’ or ‘drug therapy’.Results
Of the 73 articles matched our search terms, 61 were original articles and 12 were case reports or case series. Acneiform eruption is most commonly observed in patients treated with epidermal growth factor receptor inhibitors and mitogen-activated protein kinase inhibitors. Typical lesions consist of erythematous papules and pustules without comedones, accompanying with burning, pruritus, or xerosis. The pathogenesis involves inflammation and abnormalities of the follicular epithelium, where a disorder in EGFR signaling plays a key role. The treatment of acneiform eruption depends on the severity of the rash.Conclusions
Early recognition and effective management of this cutaneous adverse reaction can prevent unnecessary reduction and discontinuation of drug use and improve patient survival and quality of life. Close collaboration between oncologists and dermatologists is important to optimize therapy and improve patient survival. 相似文献995.
Fei Liu MM Qiujun Zhou MD Hui Wang MM Hongyang Fu MD Yuanyuan Li MD Maocan Tao MD Hongbin Luo MD Yi Cao MD 《Journal of Cosmetic Dermatology》2023,22(9):2408-2419
Background
Since there is currently no conclusion on the efficacy and adverse effects of oxymetazoline, this meta-analysis attempts to explore its efficacy and adverse events, so as to provide guidance for clinical medication.Methods
We searched PubMed, Embase, and Cochrane Library from the establishment of the database to May 2021. We included studies that patients were randomly assigned to receive oxymetazoline or vehicle, and we excluded duplicate publications, research without full text, incomplete information or inability to conduct data extraction, animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data.Results
The pooled results show that the 3 (RR = 1.76, 95% CI: 1.53–2.03), 6 (RR = 1.71, 95% CI: 1.47–2.00), 9 (RR = 1.63, 95% CI: 1.40–1.90), 12 (RR = 1.41, 95% CI: 1.18–1.67) -hours CEA success rate and the 3 (RR = 1.65, 95% CI: 1.34–2.03), 6 (RR = 1.75, 95% CI: 1.43–2.14), 9 (RR = 1.63, 95% CI: 1.33–2.00), 12 (RR = 1.78, 95% CI: 1.45–2.18) -hours SSA success rate after oxymetazoline treatment for rosacea is significantly higher than that of vehicle. Additionally, the pooled results show that the incidence of TEAEs after treatment with oxymetazoline is significantly higher than that of vehicle (RR = 1.34, 95% CI: 1.10–1.2). However, our analysis of specific adverse events found that the oxymetazoline group was only significantly higher than the vehicle group in the incidence of application-site dermatitis (RR = 8.91, 95% CI: 1.76–45.23), and there was no statistical significance in the difference in the incidence of other adverse events.Conclusion
Oxymetazoline is effective and can be selected for the treatment of persistent facial erythema of rosacea. Additionally, application-site dermatitis was the most important one. 相似文献996.
Yue Liu MM Yuchen Cao MM Xueshang Su MM Shasha Li MB Maomei Dou MB Chunan Qu MM Jintian Hu MD Lianzhao Wang MD 《Journal of Cosmetic Dermatology》2023,22(11):3095-3099
Background
The high recurrence rate after nonsurgical treatment of keloid is a major challenge for clinicians. Although there are many existing treatment options, how to optimize and upgrade the existing options and make a reasonable combination of utilization is our concern. The aim of this study is to provide a comprehensive non-surgical treatment for keloid—cocktail therapy.Methods
According to the different changes of keloid with treatment, the treatment was divided into four stages, and different treatment schemes were adopted for each stage. The incidence of side effects of keloid at each stage and the effective rate and cure rate 16 months after the end of treatment were analyzed.Results
All patients completed this study on time, and were followed up 16 months after the end of treatment, the treatment effective rate was 100%, and the cure rate was up to 92.8%.Conclusion
Cocktail therapy can achieve a higher cure rate of keloid, and is worthy of clinical promotion. 相似文献997.
998.
999.
1000.